Holen Sie sich die Stockscreener-App
119.91
0.79%
-0.96
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$120.87
Offen:
$121.34
24-Stunden-Volumen:
383.98K
Relative Volume:
0.88
Marktkapitalisierung:
$7.62B
Einnahmen:
$3.87B
Nettoeinkommen (Verlust:
$386.60M
KGV:
20.54
EPS:
5.8371
Netto-Cashflow:
$323.86M
1W Leistung:
-3.20%
1M Leistung:
-8.00%
6M Leistung:
-4.84%
1J Leistung:
-9.96%
1-Tages-Spanne:
$119.73
$121.97
1-Wochen-Bereich:
$119.22
$124.67
52-Wochen-Spanne:
$103.23
$146.91
Aptargroup Inc Stock (ATR) Company Profile
Firmenname
Aptargroup Inc
Sektor
Telefon
(815) 477-0424
Adresse
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Compare ATR vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATR
Aptargroup Inc
|
119.91 | 7.88B | 3.87B | 386.60M | 323.86M | 5.8371 |
ISRG
Intuitive Surgical Inc
|
391.95 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-11-03 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-01-07 | Eingeleitet | Raymond James | Outperform |
| 2025-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2024-04-29 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-01-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-08-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-10-14 | Eingeleitet | Seaport Global Securities | Neutral |
| 2020-04-27 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-03-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-02-26 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-07-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-04-05 | Bestätigt | BofA/Merrill | Underperform |
| 2019-02-27 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-05-18 | Eingeleitet | Jefferies | Hold |
| 2016-12-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2016-10-13 | Eingeleitet | Jefferies | Hold |
| 2016-01-05 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2015-11-02 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2015-09-15 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2015-05-01 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2013-02-19 | Bestätigt | Deutsche Bank | Hold |
| 2013-01-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2012-07-10 | Herabstufung | KeyBanc Capital Mkts | Buy → Hold |
| 2012-04-11 | Eingeleitet | KeyBanc Capital Mkts | Buy |
| 2011-06-13 | Hochstufung | KeyBanc Capital Mkts | Hold → Buy |
Alle ansehen
Aptargroup Inc Aktie (ATR) Neueste Nachrichten
Confluence Investment Management LLC Sells 16,696 Shares of AptarGroup, Inc. $ATR - MarketBeat
AptarGroup, Inc. (ATR) Stock Forecasts - Yahoo Finance
Zacks Research Forecasts AptarGroup's Q3 Earnings (NYSE:ATR) - MarketBeat
ETFs Investing in AptarGroup, Inc. Stocks - TradingView
AptarGroup, Inc. (ATR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zacks Industry Outlook Highlights Avery Dennison, AptarGroup and Karat Packaging - Yahoo Finance
AptarGroup's Bottom Line Pressures Are Preventing An Upgrade (NYSE:ATR) - Seeking Alpha
AptarGroup, Inc. (ATR) stock price, news, quote and history - Yahoo Finance Singapore
Aptar Pharma and Macquarie University Collaborate to Advance Inhaled Biologics Through Australian Research Council-Supported Program - Hastings Tribune
ATR6237250 Bond Profile: Coupon and Redemption - TradingView
AptarGroup, Inc. (NYSE:ATR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
AptarGroup Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Putin takes control of Aptar plant in Russia - Plastics News
AptarGroup (ATR) Could Be 20% Undervalued On MGH Research Partnership - finance.yahoo.com
Form 8K AptarGroup Inc For: 21 September - Investing.com India
AptarGroup Russian subsidiary placed under temporary external administration By Investing.com - Investing.com Nigeria
Form 8K AptarGroup Inc For: 21 September By Investing.com - Investing.com Nigeria
AptarGroup Russian subsidiary placed under temporary external administration - Investing.com
AptarGroup Russian Subsidiary Placed Under Temporary State Control - marketscreener.com
Russian decree affects small AptarGroup (NYSE: ATR) unit - Stock Titan
AptarGroup says Russian subsidiary placed under temporary external administration - TradingView
Russia puts Aptar Europe Holding under temporary administration - marketscreener.com
AptarGroup, Inc. (ATR) Stock Analysis: Exploring A 36.73% Potential Upside - DirectorsTalk Interviews
Bank of America Corp DE Takes Position in AptarGroup, Inc. $ATR - MarketBeat
Aptargroup Stock Price Forecast. Should You Buy ATR? - StockInvest.us
Corient Private Wealth LP Has $15.15 Million Position in AptarGroup, Inc. $ATR - MarketBeat
Transcript : AptarGroup, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11 - marketscreener.com
Reynders McVeigh Capital Management LLC Has $23.37 Million Stock Holdings in AptarGroup, Inc. $ATR - MarketBeat
Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery - aptar.com
AptarGroup, Mass General Partner on Nose-to-Brain Drug Delivery Research - marketscreener.com
AptarGroup, Inc. (ATR) Investor Outlook: Assessing a 36% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Squarepoint Ops LLC Invests $2.66 Million in AptarGroup, Inc. $ATR - MarketBeat
Aptar Pharma Expands Preservative Free Technology Production in Latin America - BioSpace
AptarGroup Names Interim Chief Accounting Officer Ackerman - theglobeandmail.com
Aditya J. Gandhi resigns as AptarGroup chief accounting officer; Daniel Ackerman named interim - TradingView
AptarGroup (ATR) names interim accounting chief after Gandhi exit - Stock Titan
Aptargroup, Inc. Announces Management Changes, Effective from September 11, 2026 - marketscreener.com
Aceso Therapeutics advances ACT-101 with Aptar collaboration - BioWorld News
Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis - BioSpace
AptarGroup, Inc. (ATR) Stock Analysis: A 33.54% Potential Upside Beckons Investors - DirectorsTalk Interviews
Public Employees Retirement System of Ohio Invests $2.46 Million in AptarGroup, Inc. $ATR - MarketBeat
Empowered Funds LLC Makes New $990,000 Investment in AptarGroup, Inc. $ATR - MarketBeat
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock By Investing.com - Investing.com South Africa
AptarGroup (ATR) Chief Human Resources Officer Shiela Vinczeller Sells 765 Shares - GuruFocus
AptarGroup CHRO Shiela Vinczeller Sells 765 Shares of Common Stock at $130.37 Average Price - Kalkine Media
Aptargroup CHRO Shiela Vinczeller sells $99,732 in company stock - Investing.com India
AptarGroup (NYSE: ATR) officer plans 765-share sale after $400K June trade - Stock Titan
AptarGroup Names Gael Touya as CEO and Adds Him to Board of Directors - kalkinemedia.com
AptarGroup adds CEO Gael Touya to board - Stock Titan
AptarGroup, Inc. (ATR) Stock Analysis: Strong Buy Ratings Signal Potential 27.94% Upside - DirectorsTalk Interviews
Resilient AptarGroup stock holds near $133 as insider sale follows strong Q2 2026 beat - ad-hoc-news.de
Finanzdaten der Aptargroup Inc-Aktie (ATR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):